课题基金 / 基金详情

Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease

Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease
膳食胆碱、肠道微生物群和慢性肾病的易感性
批准号:
9323444
负责人:
Stanley L Hazen
金额:
$68.96万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-20 至 2019-06-30
关键词:
AffectAgonistAnimal ModelAssessment toolAttenuatedBile AcidsBiochemicalBiologicalBlood CirculationCardiovascular DiseasesCarnitineCholesterolCholineChronicChronic Kidney FailureClinicalClinical ResearchCommunitiesCoronary heart diseaseDataDevelopmentDiagnostic testsDietDiet ModificationDietary InterventionDiseaseDisease ProgressionDisease modelDisease susceptibilityEarly DiagnosisEnzymesExcisionFibrosisFlavinsFramingham Heart StudyFunctional disorderGenerationsGenetic EngineeringGerm-FreeGoalsGraft RejectionHepaticHumanImpairmentInbred Strains MiceIndividualIntestinesKidneyLecithinLinkLyaseMediatingMediator of activation proteinMetabolic PathwayMetabolismMicrobeMissionMixed Function OxygenasesMorbidity - disease rateMusNational Institute of Diabetes and Digestive and Kidney DiseasesNephrotoxicNutrientPathway interactionsPatientsPeptidesPhysiologyPlasmaPlayPredispositionPreventionPrevention approachPreventive measureProcessPublic HealthRenal functionRiskRodentRoleSterolsSupplementationSymbiosisSystemTestingTherapeuticToxinTransplantationadverse outcomeage relatedaging populationantimicrobialbasecardiovascular disorder riskcohortcostdisease phenotypefecal transplantationfunctional disabilitygut microbiotain vivoinhibitor/antagonistinsightmetabolomicsmicrobialmortalitynephrotoxicitynew therapeutic targetnovelnovel diagnosticsoutcome forecastpublic health relevanceresponsereverse cholesterol transportsmall moleculetargeted agenttargeted treatmenttherapeutic targettransmission processtrimethylaminetrimethyloxamine

项目摘要

项目成果

Stanley L Hazen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Chronic kidney disease (CKD) affects many patients, particularly in the aging population with significant morbidity resulting in a costly public health problem. There is increasing realization for the importance of early detection and prevention, but to date there are few effective preventive measures. We have exciting preliminary data that suggest a novel, diet-induced gut microbiota-mediated pathway may serve as direct contributor to CKD susceptibility and adverse prognosis. In the present application we will interrogate each facet of the dietary-induced gut microbial pathway at the biochemical, animal model, and human clinical level. We will examine the role of specific chronic dietary exposures in risk for adverse CKD progression. We will examine the role of gut microbes in CKD susceptibility, and specific microbial enzyme systems in this process. We also will perform large scale human clinical studies testing whether gut microbial generated products detected in the circulation predict incident risk for development and progression of CKD. Finally, we will explore the potential efficacy of novel anti-microbial targeted therapy and dietary modifications for the prevention of dietary-induced CKD. Successful completion of the proposed studies should provide both important mechanistic insights into a new pathway that contributes to CKD development, as well as develop novel diagnostic tests and therapeutic approaches for the prevention of CKD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gut Microbiota and Cardiometabolic Diseases
  • 批准号:
    10004722
  • 项目类别:
  • 资助金额:
    $242.39万
  • 财政年份:
    2019
  • 负责人:
    Stanley L Hazen
  • 依托单位:
Gut Microbiota and Cardiometabolic Diseases
  • 批准号:
    9790523
  • 项目类别:
  • 资助金额:
    $244.53万
  • 财政年份:
    2019
  • 负责人:
    Stanley L Hazen
  • 依托单位:
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes
  • 批准号:
    10653050
  • 项目类别:
  • 资助金额:
    $52.33万
  • 财政年份:
    2019
  • 负责人:
    Stanley L Hazen
  • 依托单位:
Gut Microbiota and Cardiometabolic Diseases
  • 批准号:
    10653038
  • 项目类别:
  • 资助金额:
    $242.53万
  • 财政年份:
    2019
  • 负责人:
    Stanley L Hazen
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: